Trials / Completed
CompletedNCT01017276
A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
A Phase 3 Study in Patients With Chronic Kidney Disease (CKD) With Hyperphosphatemia on Peritoneal Dialysis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, open-labeled, non-comparative study to examine the safety and efficacy of ASP1585 in chronic kidney disease and hyperphosphatemia patients on peritoneal dialysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1585 | oral |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2009-11-20
- Last updated
- 2015-05-04
Locations
3 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01017276. Inclusion in this directory is not an endorsement.